Reproductive Health Matters
Volume 17, Issue 33 , Pages 61-69 , May 2009

Non-physician clinicians can safely provide first trimester medical abortion

  • Jillian Yarnall

      Affiliations

    • Program Research Assistant, Gynuity Health Projects, New York NY, USA
    • ,
  • Yael Swica

      Affiliations

    • Senior Medical Associate, Gynuity Health Projects, New York NY, USA
    • ,
  • Beverly Winikoff

      Affiliations

    • President, Gynuity Health Projects, New York NY, USA

References 

  1. Dugger CW. Lacking doctors, Africa is training substitutes. New York Times. 23 November 2004;
  2. World Health Organization Western Pacific Region. Mid-level and nurse practitioners in the Pacific: models and issues. Manila: WHO; 2001;
  3. World Health Organization. Safe abortion: Technical and policy guidance for health systems. Geneva: World Health Organization; 2003;At: < www.who.int/reproductivehealth/publications/safe_abortion/safe_abortion.pdf>. Accessed 25 September 2008
  4. Mittman DE, Cawley JF, Fenn WH. Physician assistants in the United States. British Medical Journal. 2002;325(7362):485–487
  5. da Luz Vaz M, Bergstrom S. Mozambique: delegation of responsibility in the area of maternal care. International Journal of Gynecology and Obstetrics. 1992;38(Suppl):S37–S39
  6. Libombo A, Bay Usta M. Mozambique abortion situation: country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa; 2001.
  7. Oguttu M, Odongo P. Midlevel providers' role in abortion care: Kenya country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference Report. South Africa; 2001.
  8. Jonsson I, Zatterstrom C, Sundstrom K. Midwives' role in management of medical abortion: Swedish country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa; 2001.
  9. Skilled care during childbirth. New York City: Family Care International; 2002;
  10. Sekscenski ES, Sansom S, Bazell C, et al. State practice environments and the supply of physician assistants, nurse practitioners, and certified nurse-midwives. New England Journal of Medicine. 1994;331(19):1266–1271
  11. National Abortion Federation. The role of physician assistants, nurse practitioners, and nurse-midwives in providing abortions: Strategies for Expanding Abortion Access. Washington DC: NAF; 1997;
  12. Ipas, IHCAR. Deciding women's lives are worth saving: expanding the role of midlevel providers in safe abortion care. Chapel Hill, 2002. At: < www.ipas.org/Publications/asset_upload_file460_2494.pdf>. Accessed 23 September 2008
  13. Long C, Ren N. Abortion in Cambodia: country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa; 2001.
  14. Akhter HH. Midlevel provider in menstrual regulation, Bangladesh experience. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa; 2001.
  15. Dickson-Tetteh K, Billings DK. Abortion care services provided by registered midwives in South Africa. International Family Planning Perspectives. 2002;28(3):7
  16. van der Westhuizen C. Midwifes' roles in expanding access to and the management of safe abortion care: South African country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa, 2001.
  17. Nghia DT, Khe ND. Vietnam abortion situations: country report. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Ipas conference report. South Africa; 2001.
  18. Warriner IK, Meirik O, Hoffman M, et al. Rates of complication in first-trimester manual vacuum aspiration abortion done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial. Lancet. 2006;368(9551):1965–1972
  19. Bhatia S, Faruque AS, Chakraborty J. Assessing menstrual regulation performed by paramedics in rural Bangladesh. Studies in Family Planning. 1980;11(6):213–218
  20. Joffe C, Yanow S. Advanced practice clinicians as abortion providers: current developments in the United States. Reproductive Health Matters. 2004;12(24 Suppl):198–206
  21. Kruse B. Advanced practice clinicians and medical abortion: increasing access to care. Journal of American Medical Women's Association. 2000;55(3 Suppl):167–168
  22. Freedman MA, Jillson DA, Coffin RR, et al. Comparison of complication rates in first trimester abortions performed by physician assistants and physicians. American Journal of Public Health. 1986;76(5):550–554
  23. Berer M. Provision of abortion by mid-level providers: international policy, practice and perspectives. Bulletin of World Health Organization. 2009;87:58–63
  24. Goldman MB, Occhiuto JS, Peterson LE, et al. Physician assistants as providers of surgically induced abortion services. American Journal of Public Health. 2004;94(8):1352–1357
  25. Center for Reproductive Rights. Promote access to the full range of abortion technologies: remove barriers to medical abortion. CRR; 2005. At: < www.reproductiverights.org/pdf/pub_bp_tk_technologies1.pdf>. Accessed 30 September 2008
  26. International Consensus Conference on Non-surgical (Medical) Abortion in Early First Trimester on Issues Related to Regimens and Service Delivery: frequently asked clinical questions about medical abortion. Bellagio: WHO; 2006;At: < http://who.int/reproductive-health/publications/medical_abortion/faq.pdf>. Accessed 25 September 2008
  27. World Health Organization. Medical methods for termination of pregnancy. Geneva: WHO; 1997;At: < http://whqlibdoc.who.int/trs/WHO_TRS_871.pdf>. Accessed 25 September 2008
  28. World Health Organization. Making pregnancy safer: the critical role of the skilled attendant: a joint statement by WHO, ICM, and FIGO. Geneva: WHO; 2004;At: < http://whqlibdoc.who.int/publications/2004/9241591692.pdf>. Accessed 25 September 2008
  29. Abuabara K, Blum J. Providing medical abortion in developing countries: an introductory guidebook. New York: Gynuity Health Projects; 2004;At: < http://gynuity.org/downloads/MA_guidebook_fre.pdf>. Accessed 23 September 2008
  30. International Confederation of Midwives. Essential competencies for basic midwifery practice, 2002. The Hague: ICM; 2002;At: < www.internationalmidwives.org/Portals/5/Documentation/Essential%20Compsenglish_2002-JF_2007%20FINAL.pdf>. Accessed 25 September 2008
  31. Afable-Munsuz A, Gould H, Stewart F, et al. Provider practice models for and costs of delivering medication abortion: evidence from 11 US abortion care settings. Contraception. 2007;75(1):45–51
  32. Kruse B, Gordon R, Tanenhaus J. The role of midlevel providers in abortion care in the United States. Expanding access: advancing the roles of midlevel providers in menstrual regulation and elective abortion care. Conference report. South Africa; 2001.
  33. Jones RK, Henshaw SK. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspectives in Sexual and Reproductive Health. 2002;34(3):154–161
  34. Andrews GD, French K, Wilkinson CL. Appropriately trained nurses are competent at inserting intrauterine devices: an audit of clinical practice. European Journal of Contraception & Reproductive Health Care. 1999;4(1):41–44
  35. Mundle S, Elul B, Anand A, et al. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Contraception. 2007;76(1):66–70
  36. Coyaji K. Early medical abortion in India: three studies and their implications for abortion services. Journal of American Medical Womens Association. 2000;55(3 Suppl):191–194
  37. Coyaji K, Elul B, Krishna U, et al. Mifepristone abortion outside the urban research hospital setting in India. Lancet. 2001;357(9250):120–122
  38. Jones RK, Zolna MR, Henshaw SK, et al. Abortion in the United States: incidence and access to services, 2005. Perspectives in Sexual and Reproductive Health. 2008;40(1):6–16
  39. Samora JB, Leslie N. The role of advanced practice clinicians in the availability of abortion services in the United States. Journal of Obstetrics Gynecology and Neonatal Nursing. 2007;36(5):471–476
  40. Grimes DA, Benson J, Singh S, et al. Unsafe abortion: the preventable pandemic. Lancet. 2006;368(9550):1908–1919
  41. Murthy A, Creinin MD. Pharmacoeconomics of medical abortion: a review of cost in the United States, Europe and Asia. Expert Opinion Pharmacotherapy. 2003;4(4):503–513
  42. Creinin MD. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception. 2000 Sep;62(3):117–124
  43. Hamoda H, Ashok PW, Flett GM, et al. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. BJOG. 2005;112(8):1102–1108
  44. Sharma S, El-Refaey H, Mitchel H, et al. Mifepristone vaginally in an early medical abortion regimen: a pilot study. Contraception. 2006;73(3):261–264
  45. Ravn P, Rasmussen A, Knudsen UB, et al. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion. Acta Obstetricia et Gynecologica Scandinavica. 2005;84(11):1098–1102
  46. Ellertson C, Simonds W, Winikoff B, et al. Providing mifepristone-misoprostol medical abortion: the view from the clinic. Journal of American Medical Women's Association. 1999;54(2):91–96
  47. Beckman LJ, Harvey SM, Satre SJ. The delivery of medical abortion services: the views of experienced providers. Women's Health Issues. 2002;12(2):103–112
  48. Ngoc NTN, Winikoff B, Clark S, et al. Safety, efficacy and acceptability of mifespristone-misoprostol medical abortion in Vietnam. International Family Planning Perspectives. 1999;25(1):10–14
  49. Hajri S, Ben Aissa R, Dabash R, et al. Ten years of medical abortion services and innovations in Tunisia. European Journal of Contraception & Reproductive Health Care. 2008;13(1):25–26
  50. Hajri S. Medical abortion: the Tunisian experience. African Journal of Reproductive Health. 2004;8(1):63–69
  51. Royal College of Obstetricians and Gynaecologists. National evidence-based clinical guidelines: the care of women requesting induced abortion. London: RCOG; 2004;
  52. Clark WH, Gold M, Grossman D, et al. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception. 2007;75(4):245–250
  53. Ashok PW, Flett GM, Templeton A. Termination of pregnancy at 9–13 weeks' amenorrhoea with mifepristone and misoprostol. Lancet. 1998;352(9127):542–543
  54. Gouk EV, Lincoln K, Khair A, et al. Medical termination of pregnancy at 63 to 83 days gestation. British Journal of Obstetrics and Gynaecology. 1999;106(6):535–539
  55. Shannon C, Winikoff B. How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion. Women's Health. 2008;4(2):5
  56. Shannon C, Brothers LP, Philip NM, et al. Ectopic pregnancy and medical abortion. Obstetrics and Gynecology. 2004;104(1):161–167
  57. Edwards J, Carson SA. New technologies permit safe abortion at less than six weeks' gestation and provide timely detection of ectopic gestation. American Journal of Obstetrics and Gynecology. 1997;176(5):1101–1106
  58. Kaali SG, Csakany GM, Szigetvari I, et al. Updated screening protocol for abortion services. Obstetrics and Gynecology. 1990;76(1):136–138
  59. Centers for Disease Control and Prevention. Ectopic Pregnancy - United States, 1990–1992. Morbidity and Mortality Weekly Report. 1995;44:46–48
  60. Grossman D, Ellertson C, Grimes DA, et al. Routine follow-up visits after first-trimester induced abortion. Obstetrics and Gynecology. 2004;103(4):738–745
  61. Taylor D, Hwang AC. Mifepristone for medical abortion. Exploring a new option for nurse practitioners. Journal of Association of Women's Health, Obstetric, and Neonatal Nurses Lifelines. 2003/2004;7(6):524–529

PII: S0968-8080(09)33445-X

doi: 10.1016/S0968-8080(09)33445-X

Reproductive Health Matters
Volume 17, Issue 33 , Pages 61-69 , May 2009

Article Tools

* Image Usage & Resolution